Organon Discontinued
FDA Approved Drugs
Organon Discontinued
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 24
- Latest Approval Date May 03, 2013
- Data Source FDA
- First Approval Date Jul 10, 1984
Company Overview
Social Profiles
Company Snapshot
FDA Approved Drug Records ( 24 records )
Drug Name
CLARINEX
Product Number
1
Dosage Form
-
Strength
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2002-06-26
Active Ingredient
DESLORATADINE
Application Number
21312
Product Number
1
Dosage Form
-
Strength
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2002-06-26
Regulatory Status
Discontinued
Drug Name
CLARINEX
Product Number
2
Dosage Form
-
Strength
2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2005-07-14
Active Ingredient
DESLORATADINE
Application Number
21312
Product Number
2
Dosage Form
-
Strength
2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2005-07-14
Regulatory Status
Discontinued
Drug Name
CLARINEX D 24 HOUR
Product Number
1
Dosage Form
-
Strength
5MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2005-03-03
Active Ingredient
DESLORATADINE; PSEUDOEPHEDRINE SULFATE
Application Number
21605
Product Number
1
Dosage Form
-
Strength
5MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2005-03-03
Regulatory Status
Discontinued
Drug Name
DIPROLENE
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-08-01
Active Ingredient
BETAMETHASONE DIPROPIONATE
Application Number
19716
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1988-08-01
Regulatory Status
Discontinued
Drug Name
DIPROLENE AF
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1987-04-27
Active Ingredient
BETAMETHASONE DIPROPIONATE
Application Number
19555
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1987-04-27
Regulatory Status
Discontinued
Drug Name
ELOCON
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
1987-04-30
Active Ingredient
MOMETASONE FUROATE
Application Number
19543
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
1987-04-30
Regulatory Status
Discontinued
Drug Name
ELOCON
Product Number
1
Dosage Form
-
Strength
0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1987-05-06
Active Ingredient
MOMETASONE FUROATE
Application Number
19625
Product Number
1
Dosage Form
-
Strength
0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1987-05-06
Regulatory Status
Discontinued
Drug Name
ELOCON
Product Number
2
Dosage Form
-
Strength
0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-04-19
Active Ingredient
MOMETASONE FUROATE
Application Number
19625
Product Number
2
Dosage Form
-
Strength
0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-04-19
Regulatory Status
Discontinued
Drug Name
ELOCON
Product Number
1
Dosage Form
-
Strength
0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1989-03-30
Active Ingredient
MOMETASONE FUROATE
Application Number
19796
Product Number
1
Dosage Form
-
Strength
0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1989-03-30
Regulatory Status
Discontinued
Drug Name
FOSAMAX
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1995-09-29
Active Ingredient
ALENDRONATE SODIUM
Application Number
20560
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1995-09-29
Regulatory Status
Discontinued
Drug Name
FOSAMAX
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1995-09-29
Active Ingredient
ALENDRONATE SODIUM
Application Number
20560
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1995-09-29
Regulatory Status
Discontinued
Drug Name
FOSAMAX
Product Number
3
Dosage Form
-
Strength
EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1997-04-25
Active Ingredient
ALENDRONATE SODIUM
Application Number
20560
Product Number
3
Dosage Form
-
Strength
EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1997-04-25
Regulatory Status
Discontinued
Drug Name
FOSAMAX
Product Number
4
Dosage Form
-
Strength
EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2000-10-20
Active Ingredient
ALENDRONATE SODIUM
Application Number
20560
Product Number
4
Dosage Form
-
Strength
EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2000-10-20
Regulatory Status
Discontinued
Drug Name
IMPLANON
Product Number
1
Dosage Form
-
Strength
68MG/IMPLANT
Approval Date
2006-07-17
Active Ingredient
ETONOGESTREL
Application Number
21529
Product Number
1
Dosage Form
-
Strength
68MG/IMPLANT
Approval Date
2006-07-17
Regulatory Status
Discontinued
Drug Name
LIPTRUZET
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-05-03
Active Ingredient
ATORVASTATIN CALCIUM; EZETIMIBE
Application Number
200153
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-05-03
Regulatory Status
Discontinued
Drug Name
LIPTRUZET
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-05-03
Active Ingredient
ATORVASTATIN CALCIUM; EZETIMIBE
Application Number
200153
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-05-03
Regulatory Status
Discontinued
Drug Name
LIPTRUZET
Product Number
3
Dosage Form
-
Strength
EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-05-03
Active Ingredient
ATORVASTATIN CALCIUM; EZETIMIBE
Application Number
200153
Product Number
3
Dosage Form
-
Strength
EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-05-03
Regulatory Status
Discontinued
Drug Name
LIPTRUZET
Product Number
4
Dosage Form
-
Strength
EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-05-03
Active Ingredient
ATORVASTATIN CALCIUM; EZETIMIBE
Application Number
200153
Product Number
4
Dosage Form
-
Strength
EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
2013-05-03
Regulatory Status
Discontinued
Drug Name
LOTRISONE
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1984-07-10
Active Ingredient
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
Application Number
18827
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1984-07-10
Regulatory Status
Discontinued
Drug Name
MAXALT-MLT
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1998-06-29
Active Ingredient
RIZATRIPTAN BENZOATE
Application Number
20865
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1998-06-29
Regulatory Status
Discontinued
Drug Name
REMERON
Product Number
3
Dosage Form
-
Strength
45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1997-03-17
Active Ingredient
MIRTAZAPINE
Application Number
20415
Product Number
3
Dosage Form
-
Strength
45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1997-03-17
Regulatory Status
Discontinued
Drug Name
SINGULAIR
Product Number
2
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2000-03-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
20830
Product Number
2
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2000-03-03
Regulatory Status
Discontinued
Drug Name
SINGULAIR
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/PACKET
Approval Date
2002-07-26
Active Ingredient
MONTELUKAST SODIUM
Application Number
21409
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/PACKET
Approval Date
2002-07-26
Regulatory Status
Discontinued
Drug Name
ZOCOR
Product Number
5
Dosage Form
-
Strength
80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1998-07-10
Active Ingredient
SIMVASTATIN
Application Number
19766
Product Number
5
Dosage Form
-
Strength
80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1998-07-10
Regulatory Status
Discontinued
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
54 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
24 total- Discontinued
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
CLARINEX
Application Number
21312
Product Number
1
Active Ingredient
DESLORATADINE
Dosage Form
-
Strength
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.